Gandolfo G M, Afeltra A, Amendolea M A, Mannella E, Masala C
Acta Haematol. 1977;58(1):10-6. doi: 10.1159/000207800.
Three techniques have been employed for the in vitro detection of circulating platelet antibodies in thrombocytopenic patients affected by 'idiopathic' form or by lupus erythematosus (SLE), the complement fixation test, the platelet factor 3 availability test and the serotonin release test. 29 of the 35 sera tested (82.8%) gave positive results for antiplatelet activity. In particular the serotonin release test allows to distinguish 4 groups of patients: a first group affected by idiopathic form; two groups with autoimmune thrombocytopenia and various degrees of serotonin release, and finally a fourth group which comprises subjects affected by SLE, with circulating immunocomplexes.
已采用三种技术对患有“特发性”形式或红斑狼疮(SLE)的血小板减少症患者的循环血小板抗体进行体外检测,即补体结合试验、血小板第3因子有效性试验和血清素释放试验。在检测的35份血清中,有29份(82.8%)的抗血小板活性呈阳性结果。特别是血清素释放试验可以区分4组患者:第一组为特发性形式患者;两组为自身免疫性血小板减少症患者,血清素释放程度不同;最后第四组包括患有SLE且有循环免疫复合物的患者。